Clinical trial
Voriconazole to Treat Fungal Infections
NCT00001940 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001940 |
|---|---|
| Title | Voriconazole to Treat Fungal Infections |
| Official title | An Open Label, Non-Comparative, Multi-Center Phase III Trial of the Efficacy, Safety, and Toleration of Extended Voriconazole in the Treatment of Invasive Fungal Infections |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mycoses |
| Intervention type | Drug |
| Interventions | Voriconazole |
| Enrollment | 100 |
| Start date | Dec 1, 1999 |
| Completion | Jul 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: